As the authors note, the emergence of therapies with diverse mechanisms, including dual GCG/GLP-1 receptor agonism, may help enable more individualized approaches to cardiometabolic disease management
Like SGLT-2 inhibitors, GLP-1 receptor agonists do not increase the risk of hypoglycemia severe enough to require treatment, but their use can cause gastrointestinal symptoms (NNH = 18
The application of lipstick replicates this effect, which is a practice dating back centuries to ancient civilizations, such as the Egyptians
Incorporating dietary and lifestyle changes can significantly enhance the effectiveness of this treatment in your weight loss journey
It turns out healthcare providers nationwide are administering an unregulated, potentially dangerous product claimed to contain 'compounded semaglutide.' It's crucial to note that I offer FDA-approved semaglutide products as a healthcare provider, yet my primary concern is patient safety and upholding the medical profession's integrity, not competition
Tirzepatide activates two pathways